Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents | Zendy

Richard Watkins | Zendy; Marisa Holubar | Zendy; Michael David | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents

Author(s) -

Richard Watkins,

Marisa Holubar,

Michael David

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01216-19

Subject(s) - antimicrobial , staphylococcus aureus , microbiology and biotechnology , methicillin resistant staphylococcus aureus , staphylococcal infections , anti infective agents , antibiotic resistance , antibacterial agent , drug resistance , medicine , biology , antibiotics , bacteria , genetics

Infections caused by methicillin-resistantStaphylococcus aureus (MRSA) result in significant morbidity and mortality for patients in both community and health care settings. This is primarily due to the difficulty in treating MRSA, which is often resistant to multiple classes of antibiotics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research